Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II

https://adir.tums.ac.ir/article/Safety-and-efficacy-study-of-allogeneic-human-menstrual-blood-stromal-cells-secretome-to-treat-severe-COVID–19-patients:-clinical-trial-phase-I-&-II

stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II --> Background:...